Baker Lh

410 total citations
31 papers, 300 citations indexed

About

Baker Lh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Baker Lh has authored 31 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Baker Lh's work include Lung Cancer Treatments and Mutations (7 papers), Cancer therapeutics and mechanisms (6 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Baker Lh is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer therapeutics and mechanisms (6 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Baker Lh collaborates with scholars based in United States. Baker Lh's co-authors include Richard Stephens, J J Costanzi, Jones Se, Joseph M. Quagliana, E. Gehan, Talley Rw, Weick Jk, Michael Henderson, Priyanka A. Shah and Michael K. Samson and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Lung Cancer.

In The Last Decade

Baker Lh

30 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Baker Lh United States	12	169	92	71	47	35	31	300
V. Barbounis Greece	15	231 1.4×	102 1.1×	115 1.6×	72 1.5×	71 2.0×	31	481
Masaji Yamauchi Japan	10	154 0.9×	205 2.2×	100 1.4×	117 2.5×	60 1.7×	38	410
P. C. Hoffman United States	7	161 1.0×	235 2.6×	87 1.2×	45 1.0×	39 1.1×	16	488
P K Buamah United Kingdom	11	45 0.3×	99 1.1×	36 0.5×	59 1.3×	35 1.0×	20	333
Shigeki Sugiyama Japan	10	80 0.5×	75 0.8×	186 2.6×	101 2.1×	32 0.9×	39	382
Brian M.J. Cantwell United Kingdom	12	236 1.4×	126 1.4×	83 1.2×	16 0.3×	39 1.1×	21	369
W. ten Bokkel Huinink Netherlands	10	154 0.9×	87 0.9×	51 0.7×	190 4.0×	19 0.5×	17	414
P. Marpicati Italy	10	214 1.3×	56 0.6×	104 1.5×	23 0.5×	45 1.3×	36	323
Daniel Donato United States	13	140 0.8×	102 1.1×	67 0.9×	168 3.6×	29 0.8×	29	532
Tadashi Aoyama Japan	12	142 0.8×	105 1.1×	49 0.7×	59 1.3×	29 0.8×	36	357

Countries citing papers authored by Baker Lh

Since Specialization

Citations

This map shows the geographic impact of Baker Lh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baker Lh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baker Lh more than expected).

Fields of papers citing papers by Baker Lh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baker Lh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baker Lh. The network helps show where Baker Lh may publish in the future.

Co-authorship network of co-authors of Baker Lh

This figure shows the co-authorship network connecting the top 25 collaborators of Baker Lh. A scholar is included among the top collaborators of Baker Lh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baker Lh. Baker Lh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crowley, John, et al.. (1987). Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study.. PubMed. 71(11). 1095–6. 3 indexed citations

Pazdur, Richard, et al.. (1987). Phase I study of echinomycin.. PubMed. 71(12). 1217–9. 10 indexed citations

Lh, Baker, et al.. (1985). Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.. PubMed. 69(6). 709–10. 2 indexed citations

Lh, Baker, et al.. (1983). PCNU in advanced adenocarcinoma of the ovary: a phase II study.. PubMed. 67(5). 511–2. 3 indexed citations

Jk, Weick, et al.. (1983). Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study.. PubMed. 67(9). 823–5. 24 indexed citations

Lh, Baker, et al.. (1982). Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group Study.. PubMed. 66(7). 1591–1591. 7 indexed citations

Samson, Michael K., Baker Lh, Glenn Cummings, et al.. (1982). Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma.. PubMed. 66(2). 371–3. 3 indexed citations

Dindogru, Aydin, et al.. (1982). Phase II study of high-dose intermittent cycloleucine in colorectal malignancies.. PubMed. 66(1). 203–4. 2 indexed citations

Lh, Baker, et al.. (1981). Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot study.. PubMed. 64(10-11). 1139–40. 13 indexed citations

10.

Lh, Baker, et al.. (1980). Phase I-II clinical trial of gallium nitrate (NSC-15200).. PubMed. 3(2). 131–6. 12 indexed citations

11.

Lh, Baker, et al.. (1979). American experience with carminomycin.. PubMed. 63(5). 899–902. 10 indexed citations

12.

Lh, Baker, et al.. (1979). Use of VM-26 as a single agent in the treatment of renal carcinoma.. PubMed. 2(4). 293–5. 9 indexed citations

13.

OʼBryan, Robert M., et al.. (1978). Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.. PubMed. 62(10). 1599–601. 2 indexed citations

14.

Lh, Baker, et al.. (1977). Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.. PubMed. 61(1). 59–64. 3 indexed citations

15.

Lh, Baker, et al.. (1977). 5-FU infusion and cyclophosphamide in the treatment of advanced ovarian cancer.. PubMed. 61(8). 1573–5. 4 indexed citations

16.

Lh, Baker, et al.. (1977). Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.. PubMed. 61(8). 1595–7. 18 indexed citations

17.

Lh, Baker, et al.. (1976). Phase I and II evaluation of cytembena in disseminated epithelial ovarian cancers and sarcomas.. PubMed. 60(9). 1389–91. 3 indexed citations

18.

Lh, Baker, et al.. (1976). Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875).. PubMed. 60(1). 91–7. 17 indexed citations

19.

Henderson, Michael, et al.. (1976). Phase I study of oral mitomycin C.. PubMed. 60(11). 1633–6. 15 indexed citations

20.

Lh, Baker, et al.. (1974). Bony metastasis from adenocarcinoma of the colon.. PubMed. 62(2). 139–44. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact